EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Utility of Prenatal cfDNA Screening for Sex Chromosome Aneuploidies: A Single Center Experience

Ying Lin, Qun Lu, Yun Wu, Hang Li, Haoyang Feng, Chunyu Luo, Ping Hu iD, Dong Liang, Zhengfeng Xu iD

Molecular Genetics & Genomic Medicine · 2026-03 · 14 (3)

DOI: 10.1002/mgg3.70211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 23.03.2026. Verfasst von Ying Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prenatal Diagnosis, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu,…. Hauptthemen laut MEDLINE: Aneuploidy, Sex Chromosome Aberrations, Cell-Free Nucleic Acids, Sex Chromosome Disorders. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Jiangsu Province Capability Improvement Project through Science, Technology and Education Jiangsu Provincial Medical Key Discipline, Research Project of Jiangsu Province Association of Maternal and Child Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To assess the clinical efficacy of prenatal cfDNA screening for detecting sex chromosome aneuploidies (SCAs). Material and Methods We conducted a retrospective study at a single center including women with singleton pregnancies who underwent prenatal cfDNA screening between January 2020 and December 2024. Cases with high‐risk cfDNA screening results for SCAs were reviewed for confirmatory diagnostic results, prenatal ultrasound findings, and pregnancy outcomes. Positive predictive values (PPVs) were calculated for each SCA subtype, and associations between ultrasound findings and confirmed SCAs were analyzed.

Results

A total of 252 pregnancies (252/58720, 0.43%) were identified as high‐risk cfDNA screening results for SCAs, including 224 fetal and 28 maternal cases. The fetal SCAs comprised 101 cases of 45,X, 37 of 47,XXX, 55 of 47,XXY, and 31 of 47,XYY. Among them, 173 underwent invasive diagnosis, confirming 90 true SCA cases with a PPV of 52.0%. For 45,X, there was a trend toward a higher detection rate in those with abnormal ultrasound findings compared to those with normal ultrasound results (4/20 vs. 8/127, p = 0.060), though it did not reach statistical significance; no significant differences were observed for sex chromosome trisomies. Of the 16 maternal SCA cases that underwent invasive testing, all fetuses had normal karyotypes.

Conclusions

Our findings demonstrated prenatal cfDNA screening as a unique approach to achieve effective detection of fetal SCAs, particularly those that otherwise would be overlooked by routine prenatal ultrasound screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AneuploidySex Chromosome AberrationsCell-Free Nucleic AcidsSex Chromosome DisordersNoninvasive Prenatal TestingPrenatal DiagnosisHumansFemalePregnancyAdultRetrospective StudiesSex Chromosomes

Stichwörter der Autor:innen

abnormal ultrasoundcfDNA screeningmaternal sex chromosome aneuploidiessex chromosome aneuploidies

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Department of Prenatal Diagnosis, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China.
  • Department of Ultrasound, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China.

ORCID-Profile: Ping Hu, Zhengfeng Xu

Förderung

  • National Key Research and Development Program of China
  • Jiangsu Province Capability Improvement Project through Science, Technology and Education Jiangsu Provincial Medical Key Discipline
  • Research Project of Jiangsu Province Association of Maternal and Child Health

Zitieren

APA

Lin, Y., Lu, Q., Wu, Y., Li, H., Feng, H., Luo, C., Hu, P., Liang, D., & Xu, Z. (2026). Clinical Utility of Prenatal cfDNA Screening for Sex Chromosome Aneuploidies: A Single Center Experience. Molecular Genetics & Genomic Medicine, 14(3). https://doi.org/10.1002/mgg3.70211

Vancouver

Lin Y, Lu Q, Wu Y, Li H, Feng H, Luo C, et al. Clinical Utility of Prenatal cfDNA Screening for Sex Chromosome Aneuploidies: A Single Center Experience. Molecular Genetics & Genomic Medicine. 2026;14(3). doi:10.1002/mgg3.70211

BibTeX
@article{Lin2026,
  author = {Lin, Ying and Lu, Qun and Wu, Yun and Li, Hang and Feng, Haoyang and Luo, Chunyu and Hu, Ping and Liang, Dong and Xu, Zhengfeng},
  title = {Clinical Utility of Prenatal cfDNA Screening for Sex Chromosome Aneuploidies: A Single Center Experience},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/mgg3.70211}
}
Kostenlos starten →